In this issue:
Anxiety/depression: impact on chronic LBP multidisciplinary management outcomes
Efficacy and safety of tanezumab for knee/hip OA pain
Optogenetics for investigating neuropathic allodynia
Intravenous lignocaine similar to morphine for severe pain in the ED
Analgesic efficacy and safety of intrathecal betamethasone for cancer pain
Fremanezumab for preventing migraine
here we are with CIPN
CGRP and the trigeminal system in migraine
Illicit fentanyl in the opioid street market
Sleep quality/fatigue: impact on interdisciplinary chronic pain programme benefits
Please login below to download this issue (PDF)